US 11207394
Anti-mutated KRAS T cell receptors
granted A61KA61K2239/38A61K2239/54
Quick answer
US patent 11207394 (Anti-mutated KRAS T cell receptors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2239/38, A61K2239/54, A61K38/00, A61K39/001164